Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment

Daily-practice challenges in oncology have been intensified by the approval of immune checkpoint inhibitors (ICI). We aimed to outline current therapy policies and management of locally advanced unresectable stage III non-small-cell lung cancer (NSCLC) in different countries. One thoracic oncologist...

Descripción completa

Detalles Bibliográficos
Autores principales: Agbarya, Abed, Shalata, Walid, Addeo, Alfredo, Charpidou, Andriani, Cuppens, Kristof, Brustugun, Odd Terje, Rajer, Mirjana, Jakopovic, Marco, Marinca, Mihai V., Pluzanski, Adam, Hiltermann, Jeroen, Araújo, António
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949111/
https://www.ncbi.nlm.nih.gov/pubmed/35330063
http://dx.doi.org/10.3390/jcm11061738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949111/
https://www.ncbi.nlm.nih.gov/pubmed/35330063
http://dx.doi.org/10.3390/jcm11061738

Ejemplares similares